Envoy Medical, Inc.
Sembol: COCHW
NASDAQ
0.045
USDBugünkü piyasa fiyatı
-2.0601
F/K Oranı
-0.6316
PEG Oranı
41.19M
MRK Kapağı
- 0.00%
DIV Verimi
Envoy Medical, Inc. (COCHW) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 16.67 | 4.2 | 0.2 | 1.1 | ||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.net-receivables | 1.63 | 0.2 | 0 | 0.1 | ||||
balance-sheet.row.inventory | 5.56 | 1.4 | 1.3 | 1.1 | ||||
balance-sheet.row.other-current-assets | 15.14 | 1 | 0.1 | 0 | ||||
balance-sheet.row.total-current-assets | 39.01 | 6.8 | 1.6 | 2.4 | ||||
balance-sheet.row.property-plant-equipment-net | 3.31 | 0.8 | 0.9 | 0.2 | ||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.long-term-investments | 44.65 | 0 | 0 | 0.4 | ||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-non-current-assets | -44.65 | 0 | 0 | -0.4 | ||||
balance-sheet.row.total-non-current-assets | 3.31 | 0.8 | 0.9 | 0.2 | ||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-assets | 42.31 | 7.6 | 2.6 | 2.6 | ||||
balance-sheet.row.account-payables | 8.21 | 1.6 | 1 | 0.7 | ||||
balance-sheet.row.short-term-debt | 1.29 | 0.2 | 0.6 | 0.5 | ||||
balance-sheet.row.tax-payables | 0.1 | 0 | 0 | 0.1 | ||||
balance-sheet.row.long-term-debt-total | 61.46 | 0.4 | 34 | 23.5 | ||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||
balance-sheet.row.other-current-liab | 13.13 | 4.9 | 0.9 | 0.2 | ||||
balance-sheet.row.total-non-current-liabilities | 93.49 | 2.8 | 56.2 | 46.2 | ||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.capital-lease-obligations | 1.99 | 0.4 | 0.7 | 0 | ||||
balance-sheet.row.total-liab | 124.91 | 9.4 | 58.7 | 47.6 | ||||
balance-sheet.row.preferred-stock | 19.97 | 0 | 0 | 164.2 | ||||
balance-sheet.row.common-stock | 1.4 | 0 | 1.4 | 1.4 | ||||
balance-sheet.row.retained-earnings | -1025.62 | -257.2 | -226 | -210.1 | ||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.47 | -0.1 | -0.1 | -0.1 | ||||
balance-sheet.row.other-total-stockholders-equity | 922.12 | 255.6 | 168.5 | -0.4 | ||||
balance-sheet.row.total-stockholders-equity | -82.59 | -1.8 | -56.2 | -45 | ||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 42.31 | 7.6 | 2.6 | 2.6 | ||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-equity | -82.59 | -1.8 | -56.2 | -45 | ||||
balance-sheet.row.total-liabilities-and-total-equity | 42.31 | - | - | - | ||||
Total Investments | 44.65 | 0 | 0 | 0.4 | ||||
balance-sheet.row.total-debt | 63.12 | 0.6 | 34.5 | 23.5 | ||||
balance-sheet.row.net-debt | 46.45 | -3.7 | 34.4 | 22.4 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -10.82 | -29.9 | -15.9 | -8.7 | |||
cash-flows.row.depreciation-and-amortization | 0.14 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||
cash-flows.row.stock-based-compensation | 1.7 | 0 | 0 | 0 | |||
cash-flows.row.change-in-working-capital | -4 | -1 | -0.2 | -0.1 | |||
cash-flows.row.account-receivables | -0.16 | -0.2 | 0 | 0 | |||
cash-flows.row.inventory | -0.15 | 0 | -0.2 | 0.1 | |||
cash-flows.row.account-payables | -1.11 | 0.6 | 0.3 | 0.2 | |||
cash-flows.row.other-working-capital | -2.23 | -1.3 | -0.4 | -0.3 | |||
cash-flows.row.other-non-cash-items | 0.48 | 13.1 | 7.2 | 1.8 | |||
cash-flows.row.net-cash-provided-by-operating-activities | -17.13 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | -0.2 | -0.2 | -0.2 | -0.1 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -425 | |||
cash-flows.row.sales-maturities-of-investments | -389.05 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 389.19 | 0 | 0 | 425 | |||
cash-flows.row.net-cash-used-for-investing-activites | 0.06 | -0.2 | -0.2 | -0.1 | |||
cash-flows.row.debt-repayment | -11 | -10 | -8 | 0 | |||
cash-flows.row.common-stock-issued | 13.53 | 11.8 | 0.1 | 428.4 | |||
cash-flows.row.common-stock-repurchased | 387.61 | 0 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | 13.53 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 24.53 | 21.8 | 8.1 | 8.1 | |||
cash-flows.row.effect-of-forex-changes-on-cash | -0.01 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | 4.91 | 4 | -0.9 | 1 | |||
cash-flows.row.cash-at-end-of-period | 26.14 | 4.2 | 0.2 | 1.1 | |||
cash-flows.row.cash-at-beginning-of-period | 21.23 | 0.2 | 1.1 | 0.1 | |||
cash-flows.row.operating-cash-flow | -17.13 | -17.7 | -8.8 | -6.9 | |||
cash-flows.row.capital-expenditure | -0.2 | -0.2 | -0.2 | -0.1 | |||
cash-flows.row.free-cash-flow | -17.34 | -17.8 | -9 | -7.1 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0.3 | 0.3 | 0.2 | 0.3 | ||||
income-statement-row.row.cost-of-revenue | 0.96 | 0.9 | 1 | 0.8 | ||||
income-statement-row.row.gross-profit | -0.66 | -0.6 | -0.7 | -0.5 | ||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.research-development | 9.25 | - | - | - | ||||
income-statement-row.row.selling-general-administrative | 7.65 | - | - | - | ||||
income-statement-row.row.selling-and-marketing-expenses | 1.99 | - | - | - | ||||
income-statement-row.row.other-expenses | -3.82 | 0 | -7.2 | -1.8 | ||||
income-statement-row.row.operating-expenses | 18.84 | 17.8 | 8 | 6.4 | ||||
income-statement-row.row.cost-and-expenses | 19.8 | 18.7 | 8.9 | 7.2 | ||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.interest-expense | 0.04 | 0 | 0 | 0 | ||||
income-statement-row.row.selling-and-marketing-expenses | 1.99 | - | - | - | ||||
income-statement-row.row.total-other-income-expensenet | -3.34 | -11.5 | -7.2 | -1.8 | ||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||
income-statement-row.row.other-operating-expenses | -3.82 | 0 | -7.2 | -1.8 | ||||
income-statement-row.row.total-operating-expenses | -3.34 | -11.5 | -7.2 | -1.8 | ||||
income-statement-row.row.interest-expense | 0.04 | 0 | 0 | 0 | ||||
income-statement-row.row.depreciation-and-amortization | 0.14 | 0.1 | 0.1 | 0.1 | ||||
income-statement-row.row.ebitda-caps | -19.42 | - | - | - | ||||
income-statement-row.row.operating-income | -19.5 | -18.4 | -8.7 | -6.9 | ||||
income-statement-row.row.income-before-tax | -22.83 | -29.9 | -15.9 | -8.7 | ||||
income-statement-row.row.income-tax-expense | 0.09 | 0 | 0 | 0 | ||||
income-statement-row.row.net-income | -22.83 | -29.9 | -15.9 | -8.7 |
Sıkça Sorulan Sorular
Nedir Envoy Medical, Inc. (COCHW) toplam varlıklar?
Envoy Medical, Inc. (COCHW) toplam varlıklar 7640000.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir 154000.000'dur.
Firma kâr marjı nedir?
Firma kar marjı -2.222'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı -0.885'dur.
İşletme net kar marjı nedir?
Net kâr marjı -76.882'dir.
Firma toplam geliri nedir?
Toplam gelir -65.650'dur.
Nedir Envoy Medical, Inc. (COCHW) net kar (net gelir)?
Net kar (net gelir) -29908000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 562000.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 17765000.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 4945000.000'tir.